Exogenous FN1 added to NSCLC cells induces the phosphorylation of the upstream mTOR regulator AKT, reduces PTEN expression level in a time-dependent and dose-dependent manner, and inhibits the expression of two downstream mTOR regulators, LKB1 and AMPKα. Here, FN1 is linked to non-small cell lung carcinoma.